The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America

Autores
Ritacco, Viviana; Gonçalves Morgado, Marisa; García, Luis Fernando
Año de publicación
2011
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Fil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
Fil: Gonçalves Morgado, Marisa. Oswaldo Cruz Foundation (FIOCRUZ): Rio de Janeiro CEP; Brasil.
Fil: García, Luis Fernando. Grupo de Inmunología Celular e Inmunogenética (GICIG), Instituto de Investigaciones Médicas, Universidad de Antioquia, Medellin; Colombia.
The work summarizes the results of a survey on human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (MTB) situation that was undertaken within the frame of the EC FP7 EucoNet project. Updated data on HIV infection, acquired immunodeficiency syndrome (AIDS) and tuberculosis (TB) in South America are presented as well as a state of the art regarding disease management and research activities in 10 countries: Argentina, Brazil, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay and Venezuela. The average HIV prevalence is 0.5-<1.0% in most of the surveyed countries. Lower prevalences are found only in Bolivia, Chile and Ecuador. TB burden is unevenly distributed: Bolivia, Peru and Ecuador bear the highest disease loads (prevalence>140/100,000) whereas Chile, Uruguay and Venezuela bear the lowest (prevalence <25/100,000). HIV prevalence in incident TB cases ranges between 3% and 15% and mortality attributable to HIV/MTB co-infection is <1/100,000. All countries run national HIV/AIDS and TB control programmes with various degrees of efficiency and data availability/reliability. Diagnosis and treatment are free of charge and all countries adhere to diagnosis and treatment standards for TB and HIV/AIDS according to World Health Organisation guidelines. The main weaknesses are related to insufficient involvement of government administrations, poverty-related pockets of HIV/MTB co-infection in urban/suburban settings and lack of interaction between HIV/AIDS and TB programmes. Funds for HIV/AIDS are disproportionally higher than those allocated to TB and there is hardly any investment in the dual infection. Challenges and priority areas for research are presented, as stated by the South American experts at the EucoNet Workshop “Clinical and translational aspects of HIV/MTB co-infection” held in Stellenbosch, South Africa on July 23-24, 2009.
Fuente
The Open Infectious Diseases Journal 2011; 5:81-88.
Materia
Tuberculosis
VIH
Mycobacterium tuberculosis
América del Sur
Nivel de accesibilidad
acceso abierto
Condiciones de uso
Repositorio
Sistema de Gestión del Conocimiento ANLIS MALBRÁN
Institución
Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
OAI Identificador
oai:sgc.anlis.gob.ar:Publications/123456789/2232

id SGCANLIS_68c089072512157afc9d4312dc7b9e86
oai_identifier_str oai:sgc.anlis.gob.ar:Publications/123456789/2232
network_acronym_str SGCANLIS
repository_id_str a
network_name_str Sistema de Gestión del Conocimiento ANLIS MALBRÁN
spelling The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South AmericaRitacco, VivianaGonçalves Morgado, MarisaGarcía, Luis FernandoTuberculosisVIHMycobacterium tuberculosisAmérica del SurFil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Gonçalves Morgado, Marisa. Oswaldo Cruz Foundation (FIOCRUZ): Rio de Janeiro CEP; Brasil.Fil: García, Luis Fernando. Grupo de Inmunología Celular e Inmunogenética (GICIG), Instituto de Investigaciones Médicas, Universidad de Antioquia, Medellin; Colombia.The work summarizes the results of a survey on human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (MTB) situation that was undertaken within the frame of the EC FP7 EucoNet project. Updated data on HIV infection, acquired immunodeficiency syndrome (AIDS) and tuberculosis (TB) in South America are presented as well as a state of the art regarding disease management and research activities in 10 countries: Argentina, Brazil, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay and Venezuela. The average HIV prevalence is 0.5-<1.0% in most of the surveyed countries. Lower prevalences are found only in Bolivia, Chile and Ecuador. TB burden is unevenly distributed: Bolivia, Peru and Ecuador bear the highest disease loads (prevalence>140/100,000) whereas Chile, Uruguay and Venezuela bear the lowest (prevalence <25/100,000). HIV prevalence in incident TB cases ranges between 3% and 15% and mortality attributable to HIV/MTB co-infection is <1/100,000. All countries run national HIV/AIDS and TB control programmes with various degrees of efficiency and data availability/reliability. Diagnosis and treatment are free of charge and all countries adhere to diagnosis and treatment standards for TB and HIV/AIDS according to World Health Organisation guidelines. The main weaknesses are related to insufficient involvement of government administrations, poverty-related pockets of HIV/MTB co-infection in urban/suburban settings and lack of interaction between HIV/AIDS and TB programmes. Funds for HIV/AIDS are disproportionally higher than those allocated to TB and there is hardly any investment in the dual infection. Challenges and priority areas for research are presented, as stated by the South American experts at the EucoNet Workshop “Clinical and translational aspects of HIV/MTB co-infection” held in Stellenbosch, South Africa on July 23-24, 2009.Bentham Open2011info:ar-repo/semantics/articuloinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdf1874-2793https://benthamopen.com/ABSTRACT/TOIDJ-5-81http://sgc.anlis.gob.ar/handle/123456789/223210.2174/1874279301005010081The Open Infectious Diseases Journal 2011; 5:81-88.reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁNinstname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"instacron:ANLISOpen Infectious Diseases Journalenginfo:eu-repo/semantics/openAccess2025-10-16T10:11:58Zoai:sgc.anlis.gob.ar:Publications/123456789/2232Institucionalhttp://sgc.anlis.gob.ar/Organismo científico-tecnológicoNo correspondehttp://sgc.anlis.gob.ar/oai/biblioteca@anlis.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2025-10-16 10:11:58.473Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"false
dc.title.none.fl_str_mv The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America
title The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America
spellingShingle The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America
Ritacco, Viviana
Tuberculosis
VIH
Mycobacterium tuberculosis
América del Sur
title_short The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America
title_full The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America
title_fullStr The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America
title_full_unstemmed The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America
title_sort The Situation of HIV/Mycobacterium tuberculosis Co-Infection in South America
dc.creator.none.fl_str_mv Ritacco, Viviana
Gonçalves Morgado, Marisa
García, Luis Fernando
author Ritacco, Viviana
author_facet Ritacco, Viviana
Gonçalves Morgado, Marisa
García, Luis Fernando
author_role author
author2 Gonçalves Morgado, Marisa
García, Luis Fernando
author2_role author
author
dc.subject.none.fl_str_mv Tuberculosis
VIH
Mycobacterium tuberculosis
América del Sur
topic Tuberculosis
VIH
Mycobacterium tuberculosis
América del Sur
dc.description.none.fl_txt_mv Fil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
Fil: Gonçalves Morgado, Marisa. Oswaldo Cruz Foundation (FIOCRUZ): Rio de Janeiro CEP; Brasil.
Fil: García, Luis Fernando. Grupo de Inmunología Celular e Inmunogenética (GICIG), Instituto de Investigaciones Médicas, Universidad de Antioquia, Medellin; Colombia.
The work summarizes the results of a survey on human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (MTB) situation that was undertaken within the frame of the EC FP7 EucoNet project. Updated data on HIV infection, acquired immunodeficiency syndrome (AIDS) and tuberculosis (TB) in South America are presented as well as a state of the art regarding disease management and research activities in 10 countries: Argentina, Brazil, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay and Venezuela. The average HIV prevalence is 0.5-<1.0% in most of the surveyed countries. Lower prevalences are found only in Bolivia, Chile and Ecuador. TB burden is unevenly distributed: Bolivia, Peru and Ecuador bear the highest disease loads (prevalence>140/100,000) whereas Chile, Uruguay and Venezuela bear the lowest (prevalence <25/100,000). HIV prevalence in incident TB cases ranges between 3% and 15% and mortality attributable to HIV/MTB co-infection is <1/100,000. All countries run national HIV/AIDS and TB control programmes with various degrees of efficiency and data availability/reliability. Diagnosis and treatment are free of charge and all countries adhere to diagnosis and treatment standards for TB and HIV/AIDS according to World Health Organisation guidelines. The main weaknesses are related to insufficient involvement of government administrations, poverty-related pockets of HIV/MTB co-infection in urban/suburban settings and lack of interaction between HIV/AIDS and TB programmes. Funds for HIV/AIDS are disproportionally higher than those allocated to TB and there is hardly any investment in the dual infection. Challenges and priority areas for research are presented, as stated by the South American experts at the EucoNet Workshop “Clinical and translational aspects of HIV/MTB co-infection” held in Stellenbosch, South Africa on July 23-24, 2009.
description Fil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
publishDate 2011
dc.date.none.fl_str_mv 2011
dc.type.none.fl_str_mv info:ar-repo/semantics/articulo
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv 1874-2793
https://benthamopen.com/ABSTRACT/TOIDJ-5-81
http://sgc.anlis.gob.ar/handle/123456789/2232
10.2174/1874279301005010081
identifier_str_mv 1874-2793
10.2174/1874279301005010081
url https://benthamopen.com/ABSTRACT/TOIDJ-5-81
http://sgc.anlis.gob.ar/handle/123456789/2232
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Open Infectious Diseases Journal
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Bentham Open
publisher.none.fl_str_mv Bentham Open
dc.source.none.fl_str_mv The Open Infectious Diseases Journal 2011; 5:81-88.
reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁN
instname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron:ANLIS
reponame_str Sistema de Gestión del Conocimiento ANLIS MALBRÁN
collection Sistema de Gestión del Conocimiento ANLIS MALBRÁN
instname_str Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron_str ANLIS
institution ANLIS
repository.name.fl_str_mv Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
repository.mail.fl_str_mv biblioteca@anlis.gov.ar
_version_ 1846146152609611776
score 12.712165